Evgeny Krupitsky

Summary

Affiliation: St. Petersburg
Country: Russia

Publications

  1. ncbi Prevention of suicide by naltrexone in a recently detoxified heroin addict
    E M Krupitsky
    St Petersburg Regional Center for Research in Addiction and Psychopharmacology, affiliated with Pavlov State Medical University, Novo Deviatkino 19 1, St Petersburg, Leningrad Region 188661, Russia
    Eur Addict Res 7:87-8. 2001
  2. ncbi Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia
    Lauretta E Grau
    Department of Epidemiology and Public Health, Yale School of Public Health, 60 College St, New Haven, CT 06520 8034, USA
    Harm Reduct J 6:17. 2009
  3. ncbi HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
  4. ncbi Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available
    Evgeny Krupitsky
    Department of Addictions, St Petersburg Bekhterev Psychoneurological Research Institute, St Petersburg, Russia
    Curr Psychiatry Rep 12:448-53. 2010
  5. ncbi Long-acting depot formulations of naltrexone for heroin dependence: a review
    Evgeny M Krupitsky
    Laboratory of Clinical Psychopharmacology of Addictions, Valdman Institute of Pharmacology, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Curr Opin Psychiatry 23:210-4. 2010
  6. ncbi Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence
    Evgeny M Krupitsky
    Research Laboratory, St Petersburg Regional Center of Addictions and Psychopharmacology, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    J Psychoactive Drugs 39:13-9. 2007
  7. ncbi Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
    Evgeny Krupitsky
    St Petersburg Research Center of Addictions and Psychopharmacology, Novo Deviatkino 19 1, Leningrad Region 188661, Russia
    J Subst Abuse Treat 23:273-83. 2002
  8. ncbi Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence
    Evgeny Krupitsky
    Department of Pharmacology, St Petersburg Pavlov State Medical University, St Petersburg, Russia
    Arch Gen Psychiatry 69:973-81. 2012
  9. ncbi Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Lancet 377:1506-13. 2011
  10. ncbi Gender differences in neurocognitive functioning among alcohol-dependent Russian patients
    Barbara Flannery
    RTI International, Baltimore, Maryland 21224, USA
    Alcohol Clin Exp Res 31:745-54. 2007

Collaborators

  • George E Woody
  • Walter Ling
  • David R Gastfriend
  • J H Krystal
  • HENRY RICHARD KRANZLER
  • R V Gueorguieva
  • JOEL E GELERNTER
  • DIANA HANNA FISHBEIN
  • Brian Pittman
  • Ismene Petrakis
  • Lauretta E Grau
  • Barbara Flannery
  • Elliot Marseille
  • Edwin Zvartau
  • Jaakko Lappalainen
  • Ruslan Ilyuk
  • Robert Heimer
  • Mikhail Torban
  • Traci C Green
  • Ksenia Blinnikova
  • Andrei P Kozlov
  • Christian Pitter
  • Alena Peryshkina
  • Lalit Dandona
  • Jerry Coovadia
  • Joseph Saba
  • Karen Bolla
  • Elena Verbitskaya
  • Jo-Ann du Plessis
  • Nell Marshall
  • Doris Langevin
  • Sergio Bautista-Arredondo
  • James G Kahn
  • Cynthia Bland
  • Stefano M Bertozzi
  • Jo Ann Du Plessis
  • Sowedi Muyingo
  • Mead Over
  • Dmitry Lioznov
  • Marina Tsoy
  • Paul Gaist
  • Brandi Rollins
  • S G Prem Kumar
  • Natali Bushara
  • Nicci Stanley
  • Mattias Lundberg
  • Valentina Egorova
  • S G Prem Kumar
  • Jonathan Covault
  • Lucia K Somberg
  • Sofia Pchelina
  • Mikhail Remizov
  • Anastaisa Taraskina

Detail Information

Publications14

  1. ncbi Prevention of suicide by naltrexone in a recently detoxified heroin addict
    E M Krupitsky
    St Petersburg Regional Center for Research in Addiction and Psychopharmacology, affiliated with Pavlov State Medical University, Novo Deviatkino 19 1, St Petersburg, Leningrad Region 188661, Russia
    Eur Addict Res 7:87-8. 2001
    ..This case demonstrates that naltrexone can have immediate as well as long-term positive effects in persons who are attempting to recover from heroin addiction...
  2. ncbi Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia
    Lauretta E Grau
    Department of Epidemiology and Public Health, Yale School of Public Health, 60 College St, New Haven, CT 06520 8034, USA
    Harm Reduct J 6:17. 2009
    ..Future research should target the development of effective overdose recognition and prevention interventions, especially ones that include naloxone distribution and involve drug users' families...
  3. ncbi HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
    ..Information on the relationship between scale and unit costs is critical to project the cost of global HIV prevention efforts and to allocate prevention resources efficiently...
  4. ncbi Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available
    Evgeny Krupitsky
    Department of Addictions, St Petersburg Bekhterev Psychoneurological Research Institute, St Petersburg, Russia
    Curr Psychiatry Rep 12:448-53. 2010
    ..This article summarizes the results of studies conducted in Russia during the past 10 years that demonstrate these points...
  5. ncbi Long-acting depot formulations of naltrexone for heroin dependence: a review
    Evgeny M Krupitsky
    Laboratory of Clinical Psychopharmacology of Addictions, Valdman Institute of Pharmacology, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Curr Opin Psychiatry 23:210-4. 2010
    ..Long-acting sustained release formulations of naltrexone (implantable and injectable) might help to improve compliance and, thus, increase the efficacy of abstinence-oriented treatment of heroin dependence with naltrexone...
  6. ncbi Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence
    Evgeny M Krupitsky
    Research Laboratory, St Petersburg Regional Center of Addictions and Psychopharmacology, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    J Psychoactive Drugs 39:13-9. 2007
    ..It was concluded that three sessions of ketamine-assisted psychotherapy are more effective than a single session for the treatment of heroin addiction...
  7. ncbi Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
    Evgeny Krupitsky
    St Petersburg Research Center of Addictions and Psychopharmacology, Novo Deviatkino 19 1, Leningrad Region 188661, Russia
    J Subst Abuse Treat 23:273-83. 2002
    ....
  8. ncbi Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence
    Evgeny Krupitsky
    Department of Pharmacology, St Petersburg Pavlov State Medical University, St Petersburg, Russia
    Arch Gen Psychiatry 69:973-81. 2012
    ..More patients in the NI+OP than in the other groups develop wound infections or local irritation, but none are serious and all resolve with treatment. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00678418...
  9. ncbi Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Lancet 377:1506-13. 2011
    ....
  10. ncbi Gender differences in neurocognitive functioning among alcohol-dependent Russian patients
    Barbara Flannery
    RTI International, Baltimore, Maryland 21224, USA
    Alcohol Clin Exp Res 31:745-54. 2007
    ....
  11. ncbi Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use
    Diana H Fishbein
    Transdisciplinary Behavioral Science Program, RTI International, Baltimore, MD 21224, USA
    Drug Alcohol Depend 90:25-38. 2007
    ..Because the nature and degree of recovery from drug abuse are likely a function of the type or pattern of neurocognitive impairment, differential drug effects must be considered...
  12. ncbi Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar
    Brian Pittman
    NIAAA Center for the Translational Neuroscience of Alcoholism, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Alcohol Clin Exp Res 31:612-8. 2007
    ....
  13. ncbi Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population
    Jaakko Lappalainen
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516, USA
    Alcohol Clin Exp Res 29:493-8. 2005
    ..The goal of this study was to test whether GABRA2 is associated with alcohol dependence in a sample of Russian alcohol-dependent men...
  14. ncbi NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy
    John H Krystal
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Ann N Y Acad Sci 1003:176-84. 2003
    ....